Mereo BioPharma (MREO) Consolidated Net Income (2023 - 2026)
Mereo BioPharma (MREO) reported Consolidated Net Income of -$6.7 million for Q1 2026, up 47.86% year-over-year from -$4.5 million in Q1 2025, and up 8.6% quarter-over-quarter from -$7.4 million in Q4 2025.
Mereo BioPharma (MREO) Consolidated Net Income (2023 - 2026) Analysis & Trends
Mereo BioPharma (MREO) has 4 years of Consolidated Net Income data on file, last reported at -$6.7 million in Q1 2026.
- Consolidated Net Income for Q1 2026 came in at -$6.7 million, up 47.86% year-over-year; the trailing twelve-month figure through Mar 2026 was -$35.7 million (up 24.33% YoY), and the FY2025 annual result was -$41.9 million, up 3.18% from the prior year.
- Consolidated Net Income rose to -$6.7 million in Q1 2026 per MREO's latest filing, from -$7.4 million in the prior quarter.
- Over five years, Consolidated Net Income peaked at -$1.8 million in Q2 2023 and troughed at -$15.0 million in Q3 2024.
- A 4-year average of -$9.4 million and a median of -$9.0 million in 2024 frame the typical range for Consolidated Net Income.
- The sharpest annual moves came in 2024 and 2025: Consolidated Net Income sank 599.89% in 2024, then soared 53.18% in 2025.
- A 4-year view of Consolidated Net Income shows it stood at -$10.2 million in 2023, then surged by 30.74% to -$7.0 million in 2024, then decreased by 4.33% to -$7.4 million in 2025, then increased by 8.6% to -$6.7 million in 2026.
- Business Quant data shows MREO's Consolidated Net Income at -$6.7 million in Q1 2026, -$7.4 million in Q4 2025, and -$7.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.80 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.40 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.50 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.48 Mn |
| 10 | Mereo BioPharma | 252.49 Mn | 252.49 Mn | - | -6.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.72 Mn |
| Dec 31, 2025 | -7.35 Mn |
| Sep 30, 2025 | -7.02 Mn |
| Jun 30, 2025 | -14.62 Mn |
| Mar 31, 2025 | -12.89 Mn |
| Dec 31, 2024 | -7.05 Mn |
| Sep 30, 2024 | -15.00 Mn |
| Jun 30, 2024 | -12.26 Mn |
| Mar 31, 2024 | -8.95 Mn |
| Dec 31, 2023 | -10.17 Mn |
| Sep 30, 2023 | -6.53 Mn |
| Jun 30, 2023 | -1.75 Mn |
| Mar 31, 2023 | -12.08 Mn |